BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8555189)

  • 1. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
    Reddy KB; Karode MC; Harmony AK; Howe PH
    Biochemistry; 1996 Jan; 35(1):309-14. PubMed ID: 8555189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells.
    Reddy KB; Jin G; Karode MC; Harmony JA; Howe PH
    Biochemistry; 1996 May; 35(19):6157-63. PubMed ID: 8634259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
    Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O; Goetschy JF; Horisberger M; Grütter MG
    Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse TGF-beta type I receptor that requires type II receptor for ligand binding.
    Suzuki A; Shioda N; Maeda T; Tada M; Ueno N
    Biochem Biophys Res Commun; 1994 Feb; 198(3):1063-9. PubMed ID: 8117262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
    Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional association of TGF-beta receptor II with cyclin B.
    Liu JH; Wei S; Burnette PK; Gamero AM; Hutton M; Djeu JY
    Oncogene; 1999 Jan; 18(1):269-75. PubMed ID: 9926943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S; Freed TA; Gonias SL
    Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning-deletion analysis of the extracellular domain of the TGF-beta receptor type II.
    Pepin MC; Beauchemin M; Plamondon J; O'Connor-McCourt MD
    Biochem Biophys Res Commun; 1996 Mar; 220(2):289-93. PubMed ID: 8645298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
    Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII).
    Tsang ML; Zhou L; Zheng BL; Wenker J; Fransen G; Humphrey J; Smith JM; O'Connor-McCourt M; Lucas R; Weatherbee JA
    Cytokine; 1995 Jul; 7(5):389-97. PubMed ID: 7578976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
    Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
    Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
    Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
    Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway.
    Debacq-Chainiaux F; Borlon C; Pascal T; Royer V; Eliaers F; Ninane N; Carrard G; Friguet B; de Longueville F; Boffe S; Remacle J; Toussaint O
    J Cell Sci; 2005 Feb; 118(Pt 4):743-58. PubMed ID: 15671065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY; Philip A
    J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.